Martina A. Sersch, MD, Executive Medical Director at Amgen Inc., discusses Data from ARROW Trial for Multiple Myeloma Progression-free survival with KYPROLIS at Annual Meeting 2018.
Data from ARROW Trial for Multiple Myeloma Progression-free survival with KYPROLIS
